Evotec positions itself as globally leading biotechnology company that leverages its established drug discovery alliance business into high-value collaborative models between academia, non-for-profit organization, biotech and pharma. In part this is driven through the Cure X and Target X initiatives within selected indication areas of both high unmet medical need and perceived lack of innovation. The purpose of these is to prime biotech/pharma licensing and collaboration. In doing so Evotec maintains a portfolio of clinical stage assets de-risked through partnering. More recently also Evotec started to co-invest into start-up companies. In my presentation I will highlight our systematic approach at finding academic projects, accelerating these through industrialized drug discovery and partnering these to clinical-stage developers.
Information on participating / attending:
Date:
03/02/2017 16:30 - 03/02/2017 18:00
Event venue:
Feodor-Lynen-Straße 15
CRC Hannover
Room H0.072
30625 Hannover
Niedersachsen
Germany
Target group:
Scientists and scholars, Students
Email address:
Relevance:
regional
Subject areas:
Biology, Chemistry, Medicine
Types of events:
Presentation / colloquium / lecture, Seminar / workshop / discussion
Entry:
02/08/2017
Sender/author:
Dr. Jo Schilling
Department:
Presse- und Öffentlichkeitsarbeit
Event is free:
yes
Language of the text:
English
URL of this event: http://idw-online.de/en/event56717
You can combine search terms with and, or and/or not, e.g. Philo not logy.
You can use brackets to separate combinations from each other, e.g. (Philo not logy) or (Psycho and logy).
Coherent groups of words will be located as complete phrases if you put them into quotation marks, e.g. “Federal Republic of Germany”.
You can also use the advanced search without entering search terms. It will then follow the criteria you have selected (e.g. country or subject area).
If you have not selected any criteria in a given category, the entire category will be searched (e.g. all subject areas or all countries).